Literature DB >> 22147937

Prognostic immune markers in non-small cell lung cancer--letter.

Janardan P Pandey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22147937     DOI： 10.1158/1078-0432.CCR-11-2103

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  3 in total

1.  A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.

Authors:  Xuan Zou; Zhihuang Hu; Changjing Huang; Jianhua Chang
Journal:  Med Sci Monit       Date:  2020-07-02

2.  Association between IDO activity and prognosis in patients with non-small cell lung cancer after radiotherapy.

Authors:  Yaoyao Zhu; Chenxue Jiang; Yuanjun Liu; Yefei Li; He Wu; Jianguo Feng; Yaping Xu
Journal:  Ann Transl Med       Date:  2020-09

3.  Dynamic change of IDO1 activity predicts survival in patients with unresectable stage III NSCLC and chemoradiotherapy.

Authors:  Linfang Wu; Daquan Wang; Yanhua Chen; Mingmin Qian; Xin Xu; Tao Zhang; Nan Bi; Luhua Wang
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.